Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice

被引:1
|
作者
Pan, Ruangang [1 ]
Li, Pengfei [1 ]
Meyerholz, David K. [2 ]
Perlman, Stanley [1 ,3 ]
机构
[1] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA 52242 USA
[2] Univ Iowa, Dept Pathol, Iowa City, IA USA
[3] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA
基金
美国国家卫生研究院;
关键词
SARS-CoV-2; mouse adapted coronavirus; nsp4; nsp8; innate immune response;
D O I
10.1128/jvi.00584-24
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has resulted in substantial morbidity and mortality. The basis of severe disease in humans is difficult to determine without the use of experimental animal models. Mice are resistant to infection with ancestral strains of SARS-CoV-2, although many variants that arose later in the pandemic were able to directly infect mice. In almost all cases, viruses that naturally infected mice or were engineered to enable mouse infection required mouse passage to become virulent. In most cases, changes in structural and nonstructural changes occurred during mouse adaptation. However, the mechanism of increased virulence in mice is not understood. Here, using a recently described strain of mouse-adapted SARS-CoV-2 (rSARS2-MA30N501Y), we engineered a series of recombinant viruses that expressed a subset of the mutations present in rSARS2-MA30N501Y. Mutations were detected in the spike protein and in three nonstructural proteins (nsp4, nsp8, and nsp9). We found that infection of mice with recombinant SARS-CoV-2 expressing only the S protein mutations caused very mild infection. Addition of the mutations in nsp4 and nsp8 was required for complete virulence. Of note, all these recombinant viruses replicated equivalently in cultured cells. The innate immune response was delayed after infection with virulent compared to attenuated viruses. Further, using a lineage tracking system, we found that attenuated virus was highly inhibited in the ability to infect the parenchyma, but not the airway after infection. Together, these results indicate that mutations in both the S protein and nonstructural proteins are required for maximal virulence during mouse adaptation. IMPORTANCE Understanding the pathogenesis of coronavirus disease 2019 (COVID-19) requires the study of experimental animals after infection with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). For this purpose, several mouse-adapted SARS-CoV-2 strains have been developed. Here, using a strain of mouse-adapted virus that causes a range of diseases ranging from mild to severe, we show that mutations in both a structural protein [spike (S) protein] and nonstructural proteins are required for maximal virulence. Thus, changes in the S protein, the most widely studied viral protein, while required for mouse adaptation, are not sufficient to result in a virulent virus. Understanding the pathogenesis of coronavirus disease 2019 (COVID-19) requires the study of experimental animals after infection with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2). For this purpose, several mouse-adapted SARS-CoV-2 strains have been developed. Here, using a strain of mouse-adapted virus that causes a range of diseases ranging from mild to severe, we show that mutations in both a structural protein [spike (S) protein] and nonstructural proteins are required for maximal virulence. Thus, changes in the S protein, the most widely studied viral protein, while required for mouse adaptation, are not sufficient to result in a virulent virus.
引用
收藏
页数:13
相关论文
共 7 条
  • [1] Molecular mechanisms involved in pathogenicity of SARS-CoV-2: Immune evasion and implications for therapeutic strategies
    Latifi-Pupovci, Hatixhe
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 153
  • [2] Activation of the Interferon Pathway in Trophoblast Cells Productively Infected with SARS-CoV-2
    Kallol, Sampada
    Martin-Sancho, Laura
    Morey, Robert
    Aisagbonhi, Omonigho
    Pizzo, Donald
    Meads, Morgan
    Chanda, Sumit K. K.
    Soncin, Francesca
    STEM CELLS AND DEVELOPMENT, 2023, 32 (9-10) : 225 - 236
  • [3] Immune responses to SARS-CoV-2 infection in Humans and ACE2 humanized mice
    Zhu, Airu
    Chen, Zhao
    Wang, Yanqun
    Zeng, Qiuhui
    Sun, Jing
    Zhuang, Zhen
    Li, Fang
    Zhao, Jingxian
    Zhao, Jincun
    Zhong, Nanshan
    FUNDAMENTAL RESEARCH, 2021, 1 (02): : 124 - 130
  • [4] Respiratory syncytial virus nonstructural proteins 1 and 2 are crucial pathogenic factors that modulate interferon signaling and Treg cell distribution in mice
    Yang, Pu
    Zheng, Junwen
    Wang, Shouyi
    Liu, Pin
    Xie, Meng
    Zhao, Dongchi
    VIROLOGY, 2015, 485 : 223 - 232
  • [5] Underlying Co-Morbidity Reveals Unique Immune Signatures in Type II Diabetes Patients Infected With SARS-CoV2
    Sengupta, Soumya
    Bhattacharya, Gargee
    Chatterjee, Sanchari
    Datey, Ankita
    Shaw, Shubham K.
    Suranjika, Sandhya
    Nath, Paritosh
    Barik, Prakash K.
    Prasad, Punit
    Chattopadhyay, Soma
    Swain, Rajeeb K.
    Parida, Ajay
    Devadas, Satish
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Induction of Innate Immune Response by TLR3 Agonist Protects Mice against SARS-CoV-2 Infection
    Tamir, Hadas
    Melamed, Sharon
    Erez, Noam
    Politi, Boaz
    Yahalom-Ronen, Yfat
    Achdout, Hagit
    Lazar, Shlomi
    Gutman, Hila
    Avraham, Roy
    Weiss, Shay
    Paran, Nir
    Israely, Tomer
    VIRUSES-BASEL, 2022, 14 (02):
  • [7] Type I interferon receptor signalling deficiency results in dysregulated innate immune responses to SARS-CoV-2 in mice
    Ogger, Patricia P.
    Martin, Minerva Garcia
    Michalaki, Christina
    Zhou, Jie
    Brown, Jonathan C.
    Du, Yue
    Miah, Kamran M.
    Habib, Omar
    Hyde, Stephen C.
    Gill, Deborah R.
    Barclay, Wendy S.
    Johansson, Cecilia
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 (11) : 1768 - 1775